USPTO serial 98615749
CYTEGRITY
Reviewed by CopyMark Law Group
Status 732Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- FIRST, VIVIAN M
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with CYTEGRITY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott D. Woldow
Scott D. Woldow Smith, Gambrell & Russell, LLP1055 Thomas Jefferson St. NWSuite 400Washington, DC 20007Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare | ACTIVE | — |
| 040 | Custom manufacture of pharmaceuticals based on cell therapy and gene therapy; Custom manufacture of medicine, namely, personalized medicine for others based on unique characteristics and conditions of the patient | ACTIVE | — |
| 042 | Research and development services relating to viral vectors, cell therapies, gene therapies, and medicines; Development of pharmaceutical preparations, viral vectors, cell therapies, gene therapies, and medicines; Stem cell research services; Stem cell gene therapy services, namely, advanced inducible stable producer technology research services designed specifically for the production of lentiviral vectors; Gene therapy research; Testing, inspection, research or development of pharmaceutical preparations for gene therapy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CSL Behring Gene Therapy, Inc.
- Other trademarks owned by CSL Behring Gene Therapy, Inc.
- Other trademarks in Class 035
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named CYTEGRITY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 1, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 1, 2026 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Sep 1, 2026 | EXT3 | SOU EXTENSION 3 FILED | — |
| Sep 1, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 2, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 2, 2026 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Mar 2, 2026 | EXT2 | SOU EXTENSION 2 FILED | — |
| Mar 2, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 24, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 24, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 24, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 24, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 1, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 4, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 4, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 29, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 14, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 14, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 13, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 24, 2024 | NWAP | NEW APPLICATION ENTERED | — |